212 related articles for article (PubMed ID: 33070094)
1. The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
Neurobiol Aging; 2021 Jan; 97():10-17. PubMed ID: 33070094
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
3. Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia.
Sun Y; Tan L; Xu W; Wang ZT; Hu H; Li JQ; Dong Q; Tan L; Yu JT;
J Alzheimers Dis; 2020; 75(3):729-737. PubMed ID: 32310173
[TBL] [Abstract][Full Text] [Related]
4. CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.
Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
Neurobiol Aging; 2020 Jul; 91():5-14. PubMed ID: 32305782
[TBL] [Abstract][Full Text] [Related]
5. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change.
Fiford CM; Sudre CH; Pemberton H; Walsh P; Manning E; Malone IB; Nicholas J; Bouvy WH; Carmichael OT; Biessels GJ; Cardoso MJ; Barnes J;
Neuroinformatics; 2020 Jun; 18(3):429-449. PubMed ID: 32062817
[TBL] [Abstract][Full Text] [Related]
6. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
7. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
[TBL] [Abstract][Full Text] [Related]
8. Associations of plasma neurofilament light chain with cognition and neuroimaging measures in community-dwelling early old age men.
Tang R; Buchholz E; Dale AM; Rissman RA; Fennema-Notestine C; Gillespie NA; Hagler DJ; Lyons MJ; Neale MC; Panizzon MS; Puckett OK; Reynolds CA; Franz CE; Kremen WS; Elman JA
Alzheimers Res Ther; 2024 Apr; 16(1):90. PubMed ID: 38664843
[TBL] [Abstract][Full Text] [Related]
9. Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment.
Naude JP; Gill S; Hu S; McGirr A; Forkert ND; Monchi O; Stys PK; Smith EE; Ismail Z;
J Alzheimers Dis; 2020; 76(3):1017-1027. PubMed ID: 32597801
[TBL] [Abstract][Full Text] [Related]
10. Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment.
Asken BM; VandeVrede L; Rojas JC; Fonseca C; Staffaroni AM; Elahi FM; Lindbergh CA; Apple AC; You M; Weiner-Light S; Brathaban N; Fernandes N; Boxer AL; Miller BL; Rosen HJ; Kramer JH; Casaletto KB
J Int Neuropsychol Soc; 2022 Jul; 28(6):588-599. PubMed ID: 34158138
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid β-amyloid
Osborn KE; Liu D; Samuels LR; Moore EE; Cambronero FE; Acosta LMY; Bell SP; Babicz MA; Gordon EA; Pechman KR; Davis LT; Gifford KA; Hohman TJ; Blennow K; Zetterberg H; Jefferson AL
Neurobiol Aging; 2018 Aug; 68():18-25. PubMed ID: 29702372
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament relates to white matter microstructure in older adults.
Moore EE; Hohman TJ; Badami FS; Pechman KR; Osborn KE; Acosta LMY; Bell SP; Babicz MA; Gifford KA; Anderson AW; Goldstein LE; Blennow K; Zetterberg H; Jefferson AL
Neurobiol Aging; 2018 Oct; 70():233-241. PubMed ID: 30036759
[TBL] [Abstract][Full Text] [Related]
13. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
Meeker KL; Butt OH; Gordon BA; Fagan AM; Schindler SE; Morris JC; Benzinger TLS; Ances BM
Neurobiol Dis; 2022 May; 166():105662. PubMed ID: 35167933
[TBL] [Abstract][Full Text] [Related]
15. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
[TBL] [Abstract][Full Text] [Related]
16. Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.
Osborn KE; Alverio JM; Dumitrescu L; Pechman KR; ; Gifford KA; Hohman TJ; Blennow K; Zetterberg H; Jefferson AL
J Alzheimers Dis; 2019; 71(1):281-290. PubMed ID: 31381510
[TBL] [Abstract][Full Text] [Related]
17. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
[TBL] [Abstract][Full Text] [Related]
18. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
[TBL] [Abstract][Full Text] [Related]
19. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
20. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
Anor CJ; Dadar M; Collins DL; Tartaglia MC
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
